The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

SureCN218782     2-morpholin-4-ylethyl 6-(4-hydroxy-6...

Synonyms: AG-L-21930, ACMC-20msyz, ANW-53823, AC1L1HSG, CTK0H7609, ...
 Svozílková,  Bysterská,  Masek,  Valenta,  Zvárová,  Farghali,  Chan,  Li,  Tang,  Wong,  Fang,  Ji,  Lau,  Wong,  Tong,  Chan,  Lai,  Niederwieser,  Maris,  Shizuru,  Petersdorf,  Hegenbart,  Sandmaier,  Maloney,  Storer,  Lange,  Chauncey,  Deininger,  Pönisch,  Anasetti,  Woolfrey,  Little,  Blume,  McSweeney,  Storb,  Schlitt,  Barkmann,  Böker,  Schmidt,  Emmanouilidis,  Rosenau,  Bahr,  Tusch,  Manns,  Nashan,  Klempnauer,  Ulinski,  Perrin,  Morris,  Houang,  Cabrol,  Grapin,  Chabbert-Buffet,  Bensman,  Deschênes,  Giurgea,  Kocík,  Málek,  Glagolicová,  Pirk,  Beniaminovitz,  Itescu,  Lietz,  Donovan,  Burke,  Groff,  Edwards,  Mancini,  Kaur,  Bedimo,  Kvanli,  Turner,  Shaw,  Margolis,  McSweeney,  Niederwieser,  Shizuru,  Sandmaier,  Molina,  Maloney,  Chauncey,  Gooley,  Hegenbart,  Nash,  Radich,  Wagner,  Minor,  Appelbaum,  Bensinger,  Bryant,  Flowers,  Georges,  Grumet,  Kiem,  Torok-Storb,  Yu,  Blume,  Storb,  Neumann,  Haidinger,  Jäger,  Grützmacher,  Griesmacher,  Müller,  Bayer,  Meisl,  Barker,  Weisdorf,  DeFor,  Blazar,  Miller,  Wagner,  Specks,  Fervenza,  McDonald,  Hogan,  Borie,  Larson,  Flores,  Campbell,  Rousvoal,  Zhang,  Higgins,  Ball,  Kudlacz,  Brissette,  Elliott,  Reitz,  Changelian,  Franco,  Tapia,  Santamaría,  Zafra,  García-Torres,  Gordon,  Pons,  Rodríguez-Iturbe,  Johnson,  Herrera-Acosta,  
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of C07908


Psychiatry related information on C07908


High impact information on C07908


Chemical compound and disease context of C07908


Biological context of C07908


Anatomical context of C07908


Associations of C07908 with other chemical compounds


Gene context of C07908


Analytical, diagnostic and therapeutic context of C07908


  1. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Karassa, F.B., Isenberg, D.A. N. Engl. J. Med. (2001) [Pubmed]
  2. Mycophenolate mofetil in Crohn's disease. Rampton, D.S., Neurath, M.F., Almer, S., D'Haens, G., Petritsch, W., Stange, E.F. Lancet (2000) [Pubmed]
  3. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy. Nowack, R., Birck, R., van der Woude, F.J. Lancet (1997) [Pubmed]
  4. Rescue therapy with mycophenolate mofetil in refractory uveitis. Kilmartin, D.J., Forrester, J.V., Dick, A.D. Lancet (1998) [Pubmed]
  5. Treatment of pemphigus vulgaris with mycophenolate mofetil. Enk, A.H., Knop, J. Lancet (1997) [Pubmed]
  6. A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report. Shapiro, R., Jordan, M.L., Scantlebury, V.P., Vivas, C., Gritsch, H.A., Casavilla, F.A., McCauley, J., Johnston, J.R., Randhawa, P., Irish, W., Hakala, T.R., Fung, J.J., Starzl, T.E. J. Urol. (1998) [Pubmed]
  7. Comparison of FK 506, mycophenolate mofetil, and aminoguanidine effects on delay of corneal allograft rejection in an experimental model of low-risk and high-risk keratoplasty. Svozílková, P., Bysterská, P., Masek, K., Valenta, Z., Zvárová, J., Farghali, H. Immunopharmacology and immunotoxicology. (2006) [Pubmed]
  8. A placebo-controlled pilot study of intensification of antiretroviral therapy with mycophenolate mofetil. Kaur, R., Bedimo, R., Kvanli, M.B., Turner, D., Shaw, L., Margolis, D. AIDS research and therapy [electronic resource]. (2006) [Pubmed]
  9. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. Beniaminovitz, A., Itescu, S., Lietz, K., Donovan, M., Burke, E.M., Groff, B.D., Edwards, N., Mancini, D.M. N. Engl. J. Med. (2000) [Pubmed]
  10. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Muraca, M., Gerunda, G., Neri, D., Vilei, M.T., Granato, A., Feltracco, P., Meroni, M., Giron, G., Burlina, A.B. Lancet (2002) [Pubmed]
  11. Mycophenolate mofetil monotherapy in liver transplantation. Stewart, S.F., Hudson, M., Talbot, D., Manas, D., Day, C.P. Lancet (2001) [Pubmed]
  12. Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study. Schlitt, H.J., Barkmann, A., Böker, K.H., Schmidt, H.H., Emmanouilidis, N., Rosenau, J., Bahr, M.J., Tusch, G., Manns, M.P., Nashan, B., Klempnauer, J. Lancet (2001) [Pubmed]
  13. Advances in transplantation tolerance. Yu, X., Carpenter, P., Anasetti, C. Lancet (2001) [Pubmed]
  14. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Barker, J.N., Weisdorf, D.J., DeFor, T.E., Blazar, B.R., Miller, J.S., Wagner, J.E. Blood (2003) [Pubmed]
  15. Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease. Neurath, M.F., Wanitschke, R., Peters, M., Krummenauer, F., Meyer zum Büschenfelde, K.H., Schlaak, J.F. Gut (1999) [Pubmed]
  16. Mycophenolate mofetil does not modify the incidence of cytomegalovirus (CMV) disease after kidney transplantation but prevents CMV-induced chronic graft dysfunction. Giral, M., Nguyen, J.M., Daguin, P., Hourmant, M., Cantarovich, D., Dantal, J., Blancho, G., Josien, R., Ancelet, D., Soulillou, J.P. J. Am. Soc. Nephrol. (2001) [Pubmed]
  17. Renal cortical vasoconstriction contributes to development of salt-sensitive hypertension after angiotensin II exposure. Franco, M., Tapia, E., Santamaría, J., Zafra, I., García-Torres, R., Gordon, K.L., Pons, H., Rodríguez-Iturbe, B., Johnson, R.J., Herrera-Acosta, J. J. Am. Soc. Nephrol. (2001) [Pubmed]
  18. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome with renal failure: impact of posttransplant immunosuppression on disease activity. Ulinski, T., Perrin, L., Morris, M., Houang, M., Cabrol, S., Grapin, C., Chabbert-Buffet, N., Bensman, A., Deschênes, G., Giurgea, I. J. Clin. Endocrinol. Metab. (2006) [Pubmed]
  19. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. Chan, T.M., Li, F.K., Tang, C.S., Wong, R.W., Fang, G.X., Ji, Y.L., Lau, C.S., Wong, A.K., Tong, M.K., Chan, K.W., Lai, K.N. N. Engl. J. Med. (2000) [Pubmed]
  20. Mycophenolate mofetil to rescue children with acute renal transplant rejection. Birkeland, S.A. Lancet (1996) [Pubmed]
  21. The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blaha, P., Bigenzahn, S., Koporc, Z., Schmid, M., Langer, F., Selzer, E., Bergmeister, H., Wrba, F., Kurtz, J., Kiss, C., Roth, E., Muehlbacher, F., Sykes, M., Wekerle, T. Blood (2003) [Pubmed]
  22. Treatment of systemic lupus erythematosus-associated type B insulin resistance syndrome with cyclophosphamide and mycophenolate mofetil. Gehi, A., Webb, A., Nolte, M., Davis, J. Arthritis Rheum. (2003) [Pubmed]
  23. Pharmacokinetics of mycophenolate mofetil in patients with autoimmune diseases compared renal transplant recipients. Neumann, I., Haidinger, M., Jäger, H., Grützmacher, H., Griesmacher, A., Müller, M.M., Bayer, P.M., Meisl, F.T. J. Am. Soc. Nephrol. (2003) [Pubmed]
  24. Systemic lupus erythematosus. Ruiz-Irastorza, G., Khamashta, M.A., Castellino, G., Hughes, G.R. Lancet (2001) [Pubmed]
  25. Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. Mehling, A., Grabbe, S., Voskort, M., Schwarz, T., Luger, T.A., Beissert, S. J. Immunol. (2000) [Pubmed]
  26. Mycophenolate mofetil inhibits regenerative repair in uranyl acetate-induced acute renal failure by reduced interstitial cellular response. Sun, D.F., Fujigaki, Y., Fujimoto, T., Goto, T., Yonemura, K., Hishida, A. Am. J. Pathol. (2002) [Pubmed]
  27. Experience with 500 simultaneous pancreas-kidney transplants. Sollinger, H.W., Odorico, J.S., Knechtle, S.J., D'Alessandro, A.M., Kalayoglu, M., Pirsch, J.D. Ann. Surg. (1998) [Pubmed]
  28. Mizoribine and mycophenolate mofetil. Ishikawa, H. Current medicinal chemistry. (1999) [Pubmed]
  29. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. McSweeney, P.A., Niederwieser, D., Shizuru, J.A., Sandmaier, B.M., Molina, A.J., Maloney, D.G., Chauncey, T.R., Gooley, T.A., Hegenbart, U., Nash, R.A., Radich, J., Wagner, J.L., Minor, S., Appelbaum, F.R., Bensinger, W.I., Bryant, E., Flowers, M.E., Georges, G.E., Grumet, F.C., Kiem, H.P., Torok-Storb, B., Yu, C., Blume, K.G., Storb, R.F. Blood (2001) [Pubmed]
  30. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis. Quéméneur, L., Flacher, M., Gerland, L.M., Ffrench, M., Revillard, J.P., Bonnefoy-Berard, N. J. Immunol. (2002) [Pubmed]
  31. Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Specks, U., Fervenza, F.C., McDonald, T.J., Hogan, M.C. Arthritis Rheum. (2001) [Pubmed]
  32. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. Gregori, S., Casorati, M., Amuchastegui, S., Smiroldo, S., Davalli, A.M., Adorini, L. J. Immunol. (2001) [Pubmed]
  33. Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients. Corry, R.J., Chakrabarti, P.K., Shapiro, R., Rao, A.S., Dvorchik, I., Jordan, M.L., Scantlebury, V.P., Vivas, C.A., Fung, J.J., Starzl, T.E. Ann. Surg. (1999) [Pubmed]
  34. Combined use of the JAK3 inhibitor CP-690,550 with mycophenolate mofetil to prevent kidney allograft rejection in nonhuman primates. Borie, D.C., Larson, M.J., Flores, M.G., Campbell, A., Rousvoal, G., Zhang, S., Higgins, J.P., Ball, D.J., Kudlacz, E.M., Brissette, W.H., Elliott, E.A., Reitz, B.A., Changelian, P.S. Transplantation (2005) [Pubmed]
  35. Effect of mycophenolate mofetil therapy on lymphocyte activation in heart transplant recipients. Weigel, G., Griesmacher, A., Karimi, A., Zuckermann, A.O., Grimm, M., Mueller, M.M. J. Heart Lung Transplant. (2002) [Pubmed]
  36. Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells. Colic, M., Stojic-Vukanic, Z., Pavlovic, B., Jandric, D., Stefanoska, I. Clin. Exp. Immunol. (2003) [Pubmed]
  37. Modulation of intra-pulmonary TGF-beta expression by mycophenolate mofetil in lupus prone MRL/lpr mice. Guo, H., Leung, J.C., Chan, L.Y., Lui, S.L., Tsang, A.W., Lai, K.N. Lupus (2005) [Pubmed]
  38. The effect of cyclosporin A on the level of big endothelin in patients one year after orthotopic heart transplantation. Kocík, M., Málek, I., Glagolicová, A., Pirk, J. Transpl. Int. (2004) [Pubmed]
  39. Mycophenolate mofetil for transplantation: new drug, old problems? Gray, D.W. Lancet (1995) [Pubmed]
  40. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Niederwieser, D., Maris, M., Shizuru, J.A., Petersdorf, E., Hegenbart, U., Sandmaier, B.M., Maloney, D.G., Storer, B., Lange, T., Chauncey, T., Deininger, M., Pönisch, W., Anasetti, C., Woolfrey, A., Little, M.T., Blume, K.G., McSweeney, P.A., Storb, R.F. Blood (2003) [Pubmed]
  41. Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation. Giaccone, L., McCune, J.S., Maris, M.B., Gooley, T.A., Sandmaier, B.M., Slattery, J.T., Cole, S., Nash, R.A., Storb, R.F., Georges, G.E. Blood (2005) [Pubmed]
  42. Outcome of de novo hepatitis C virus infection in heart transplant recipients. Ong, J.P., Barnes, D.S., Younossi, Z.M., Gramlich, T., Yen-Lieberman, B., Goormastic, M., Sheffield, C., Hoercher, K., Starling, R., Young, J., Smedira, N., McCarthy, P. Hepatology (1999) [Pubmed]
WikiGenes - Universities